Betahistine 24 Unicorn 24 mg Capsule
PDF Leaflet Revision Date: 10 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of vertigo associated with Mu00e9niu00e8reu2019s syndrome.
Dosage (summary)
24 mg to 48 mg per day in divided doses; typically one 24 mg tablet twice daily.
Special Populations
- Peptic ulcer history
- Bronchial asthma
- Severe hypotension
- Porphyria
Pregnancy & Breastfeeding
Safety during pregnancy and breastfeeding not established; avoid use during pregnancy.
Key Drug Interactions
- Antihistamines
- MAO inhibitors
Contraindications
- Hypersensitivity to betahistine
- Phaeochromocytoma
Common side effects
- Headache
- Drowsiness
- Nausea
- Dyspepsia
Counselling Points
- Take with food to reduce gastric discomfort
- Avoid driving until effects are known
Serious warnings
- Caution in peptic ulcer
- Monitor asthma patients
Important Disclaimer
The Betahistine 24 Unicorn 24 mg Capsule professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
